always refer to the specific product information Compatibility: The appropriate diluent and reconstitution conditions for any peptide must follow the relevant trial protocol or manufacturer's specification no such specification exists for retatrutide outside of clinical trials Bacteriostatic water should not be used in neonates or individuals with known benzyl alcohol sensitivity
All weight loss products (oral and GLP-1s) are not on formulary but can be accessed if approved through the prior authorization (PA) or non-formulary (NF) exceptions process
New England Journal of Medicine 2023 03 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial Rosenstock J, Frias J, Jastreboff AM, et al
Khurana says switching drugs might result in experiencing Vyvanse side effects such as heart palpitations or increased irritability that werent noticeable side effects of Adderall